News

Perrigo has acquired 85% stake of Vedants Drugs and Fine Chemicals. The company now plans to move its active pharmaceutical ingredients (API) manufacturing units from Israel and Germany

Roche has sealed a deal with Pontifax Management to build a R&D pipeline in Israel. Under the agreement, Pontifax will help Roche to identify and invest in Israeli

Stemedica Cell Technologies has requested a pre-Investigational New Drug (IND) meeting with the FDA. The purpose is to discuss a proposed IND to use Stemedica’s proprietary line of

Astellas has announced that the groundbreaking ceremony for Fermentation Technology Research Building in the Toyama Plant of its subsidiary, Astellas Toyama, will be held on August 24, 2009.

Qualitest Pharmaceuticals has issued a voluntary nationwide recall of Accusure Insulin Syringes (1/2 cc – 31 G – Short Needle) with lot number: 6JCB1 (Expiration 10/2011) – NDC

Ortho-McNeil-Janssen has reported that the FDA has issued a complete response letter regarding its New Drug Application (NDA) for carisbamate, an anti-epileptic drug in development. The NDA was

Tibotec has announced a new treatment option for children living with HIV. Two new lower dose 75mg and 150mg formulations of Prezista (darunavir) twice daily, co-administered with low-dose

The FDA has approved Sabril (vigabatrin) oral solution to treat infantile spasms in children aged 1 month to 2 years. Sabril (vigabatrin) Tablets have been approved for adult

Mach One has entered into a multi-year, sole-source agreement with PanTheryx, to supply proprietary bio-based ingredients for manufacturing a broad-spectrum pediatric diarrhea product. Through a wholly owned subsidiary